Trial reportDrugs in R&D2013
Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.
Trial report in Drugs in R&D, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Dry-powder inhaler use in primary school-aged children with asthma: a systematic review.ERJ open research · 2024Article
- Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study.Frontiers in medicine · 2023Article
- Preference for EasyhalerPatient preference and adherence · 2021Article
- Assessment of Poor Inhaler Technique in Older Patients with Asthma or COPD: A Predictive Tool for Clinical Risk and Inhaler Performance.Drugs & aging · 2020Article
- Effectiveness and Patient Satisfaction with Budesonide/Formoterol EasyhalerPulmonary therapy · 2019Article
- A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol TurbuhalerAdvances in therapy · 2019Observational
- Impact of patient satisfaction with his or her inhaler on adherence and asthma control.Allergy and asthma proceedings · 2018Observational
- Clinical Effectiveness of Budesonide/Formoterol Fumarate EasyhalerAdvances in therapy · 2018Observational
- Dose uniformity of budesonide Easyhaler® under simulated real-life conditions and with low inspiration flow rates.Chronic respiratory disease · 2018Article
- Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice.Advances in therapy · 2017Article
- Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.International journal of chronic obstructive pulmonary disease · 2016Article
- Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler.International journal of chronic obstructive pulmonary diseaseArticle
- A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone EasyhalerTherapeutic advances in respiratory diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study was to investigate patients' inhaler competence and satisfaction with the Easyhaler(®) dry powder inhaler.
designTwo open, uncontrolled, non-randomised studies.
settingReal life based on patients attending 56 respiratory clinics in Hungary.
participantsPatients with asthma or chronic obstructive pulmonary disease (COPD) (n = 1016).
interventionIn a 3-month study, adult patients (age range 18-88 years; n = 797) received twice-daily inhalations of formoterol via Easyhaler(®), and in a consequential study (from one visit to another, with 3-12 months in-between) children and adolescents (age range 4-17 years; n = 219) received salbutamol via Easyhaler(®) as needed.
main outcome measuresControl of six Easyhaler(®) handling steps and patients' satisfaction with Easyhaler(®) based on questionnaires.
resultsCorrect performances (minimum and maximum of the six steps) were noticed after one demonstration in 92-98% of the adults, 87-99% of the elderly, 81-96% of the children and 83-99% of the adolescents. These figures had markedly increased at the last visit. Repeat instructions were necessary in 26% of the cases. Investigators found Easyhaler(®) easy to teach in 87% of the patients and difficult in only 0.5%. Patients found Easyhaler(®) easy to learn and use, and the patients' (and parents') satisfaction with the inhaler was very high. Lung function values [forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF)] improved statistically significantly during the studies, indicating good inhaler competence and treatment adherence.
conclusionInvestigators found Easyhaler(®) easy to teach and patients found it easy to use, and their satisfaction with the device was high.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.